110
Views
8
CrossRef citations to date
0
Altmetric
Articles

Comprehensive Assessment of Phytochemical Potential of Tanacetum parthenium (L.): Phenolic Compounds, Antioxidant Activity, Essential Oil and Parthenolide

, , , &
Pages 614-629 | Received 28 Feb 2019, Accepted 13 Jun 2019, Published online: 17 Jul 2019
 

Abstract

Feverfew (Tanacetum parthenium L. Schultz Bip.) has a lot of secondary metabolites, such as phenols, essential oils and sesquiterpene lactones (parthenolide) which have high value in chemotaxonomy and medicine. This study was carried out to evaluate the phytochemical potential of Feverfew. Parthenolide was identified by UPLC-MRM-MS. The essential oil was extracted by Clevenger and essential oil components were identified by GC/MS. Other factors were measured by a spectrophotometer. Results showed that despite some minor differences, there was no significant difference among phytochemical parameters. The average of total phenolic content, flavonoids and anthocyanin content, were respectively 21.42, 1.9 and 0.076 mg/g DW. The antioxidant capacity of the extract in inhibiting free radicals was 74.82 %. Minimum, maximum and average of parthenolide content, were respectively 1.73, 1.86 and 1.89 mg/g DW. The average content of the essential oil was 0.84 % (V/W). Eighty-one compounds of the essential oil were separated. Seventy-seven compounds were identified which totally contained (96.64 %-98.15 %) of the total components. The main components of the essential oil were camphor (27.75 %-29.11 %), neryl acetate (8.94 %-11.05 %) and ρ-cymene (5.93 %-7.01 %), respectively. The first and the last classes of compounds were oxygenated monoterpene (62.81 %-68.38 %) and phenyl propanoides (0.16 %-0.28 %). Spiroether as a new valuable compound was detected for the first time in this plant. Results determined that climate conditions were prevailing than edaphic conditions in the stability of phytochemical compounds synthesis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.